Stock listing

A3EGRS Stock Price, News, Filings & Events — Eupraxia Pharmaceuticals, Inc.

Selected listing: A3EGRS · LSX · EUR · DE

The selected listing A3EGRS:LSX represents Eupraxia Pharmaceuticals, Inc., a company focused on developing innovative therapies for pain management and other conditions. Recently, Eupraxia has been advancing its clinical programs and engaging with regulatory bodies to facilitate the development of its lead product candidates. Investors can find updates on the company's latest news, financial filings, and upcoming events that may impact its market position. The pharmaceutical sector continues to evolve, and Eupraxia is positioned to contribute to advancements in treatment options.

A3EGRS:LSXEURDEUpdated July 21, 2026
Eupraxia Pharmaceuticals, Inc. logo
Ticker
A3EGRS:LSX
Asset type
Stock
Market cap
$403.6M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Eupraxia Pharmaceuticals, Inc. A3EGRS:LSX stock context

The selected listing A3EGRS:LSX represents Eupraxia Pharmaceuticals, Inc., a company focused on developing innovative therapies for pain management and other conditions. Recently, Eupraxia has been advancing its clinical programs and engaging with regulatory bodies to facilitate the development of its lead product candidates. Investors can find updates on the company's latest news, financial filings, and upcoming events that may impact its market position. The pharmaceutical sector continues to evolve, and Eupraxia is positioned to contribute to advancements in treatment options.

Research Eupraxia Pharmaceuticals, Inc.

Alternate listings